The effect of tolvaptan in heart failure patients with loop diuretic resistance.

Trial Profile

The effect of tolvaptan in heart failure patients with loop diuretic resistance.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Aug 2016 Status changed from recruiting to discontinued.
    • 04 Apr 2015 Status changed from not yet recruiting to recruiting, according to University Hospital Medical Information Network - Japan record.
    • 04 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top